Valdés-Mora F - Search Results

1

Transient exposure to miR-203 enhances the differentiation capacity of established pluripotent stem cells.

Salazar-Roa M, Trakala M, Álvarez-Fernández M, Valdés-Mora F, Zhong C, Muñoz J, Yu Y, Peters TJ, Graña-Castro O, Serrano R, Zapatero-Solana E, Abad M, Bueno MJ, Gómez de Cedrón M, Fernández-Piqueras J, Serrano M, Blasco MA, Wang DZ, Clark SJ, Izpisua-Belmonte JC, Ortega S, Malumbres M. Salazar-Roa M, et al. EMBO J. 2020 Aug 17;39(16):e104324. doi: 10.15252/embj.2019104324. Epub 2020 Jul 2. EMBO J. 2020. PMID: 32614092 Free PMC article.

2

Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer.

Valdés-Mora F, Song JZ, Statham AL, Strbenac D, Robinson MD, Nair SS, Patterson KI, Tremethick DJ, Stirzaker C, Clark SJ. Valdés-Mora F, et al. Genome Res. 2012 Feb;22(2):307-21. doi: 10.1101/gr.118919.110. Epub 2011 Jul 25. Genome Res. 2012. PMID: 21788347 Free PMC article.

3

Lineage specific methylation of the Elf5 promoter in mammary epithelial cells.

Lee HJ, Hinshelwood RA, Bouras T, Gallego-Ortega D, Valdés-Mora F, Blazek K, Visvader JE, Clark SJ, Ormandy CJ. Lee HJ, et al. Stem Cells. 2011 Oct;29(10):1611-9. doi: 10.1002/stem.706. Stem Cells. 2011. PMID: 21823211

4

Exploring and exploiting the aberrant DNA methylation profile of endocrine-resistant breast cancer.

Stone A, Valdes-Mora F, Clark SJ. Stone A, et al. Epigenomics. 2013 Dec;5(6):595-8. doi: 10.2217/epi.13.70. Epigenomics. 2013. PMID: 24283871 No abstract available.

5

Prostate cancer epigenetic biomarkers: next-generation technologies.

Valdés-Mora F, Clark SJ. Valdés-Mora F, et al. Oncogene. 2015 Mar 26;34(13):1609-18. doi: 10.1038/onc.2014.111. Epub 2014 May 19. Oncogene. 2015. PMID: 24837368 Review.

6

H2A.Z acetylation and transcription: ready, steady, go!

Colino-Sanguino Y, Clark SJ, Valdes-Mora F. Colino-Sanguino Y, et al. Epigenomics. 2016 May;8(5):583-6. doi: 10.2217/epi-2016-0016. Epub 2016 Apr 18. Epigenomics. 2016. PMID: 27087541 No abstract available.

7

Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.

Stirzaker C, Song JZ, Ng W, Du Q, Armstrong NJ, Locke WJ, Statham AL, French H, Pidsley R, Valdes-Mora F, Zotenko E, Clark SJ. Stirzaker C, et al. Oncogene. 2017 Mar;36(10):1328-1338. doi: 10.1038/onc.2016.297. Epub 2016 Sep 5. Oncogene. 2017. PMID: 27593931

8

Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains.

Khoury A, Achinger-Kawecka J, Bert SA, Smith GC, French HJ, Luu PL, Peters TJ, Du Q, Parry AJ, Valdes-Mora F, Taberlay PC, Stirzaker C, Statham AL, Clark SJ. Khoury A, et al. Nat Commun. 2020 Jan 7;11(1):54. doi: 10.1038/s41467-019-13753-7. Nat Commun. 2020. PMID: 31911579 Free PMC article.

9

Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer.

Achinger-Kawecka J, Valdes-Mora F, Luu PL, Giles KA, Caldon CE, Qu W, Nair S, Soto S, Locke WJ, Yeo-Teh NS, Gould CM, Du Q, Smith GC, Ramos IR, Fernandez KF, Hoon DS, Gee JMW, Stirzaker C, Clark SJ. Achinger-Kawecka J, et al. Nat Commun. 2020 Jan 16;11(1):320. doi: 10.1038/s41467-019-14098-x. Nat Commun. 2020. PMID: 31949157 Free PMC article.

10

The H2A.Z-nuclesome code in mammals: emerging functions.

Colino-Sanguino Y, Clark SJ, Valdes-Mora F. Colino-Sanguino Y, et al. Trends Genet. 2022 Mar;38(3):273-289. doi: 10.1016/j.tig.2021.10.003. Epub 2021 Oct 24. Trends Genet. 2022. PMID: 34702577 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page